CJ Wellcare's 'BioCore' Surpasses 300 Billion KRW in Cumulative Sales

Launch of Skin Probiotics Applying Individually Recognized Probiotic 'CJLP 133' from 2013
10th Anniversary Promotion Running Until January Next Year

Health functional food specialist CJ Wellcare announced on the 20th that the cumulative sales of its premium probiotic brand ‘BYOCORE,’ which celebrated its 10th anniversary this year, have surpassed 300 billion KRW.

CJ Wellcare entered the probiotic market in 2013 with ‘BYO Skin Probiotics,’ made from ‘CJLP 133,’ Korea’s first individually recognized probiotic strain. Over the past decade, the company has established top-tier microbiome research and development (R&D) capabilities in Korea, built its own production facilities for probiotics, and implemented a one-stop management system that covers direct distribution.

In February this year, CJ Wellcare rebranded its existing probiotic line to the current ‘BYOCORE’ to meet consumer demand for effective probiotics. It introduced high-dose products such as ‘BYOCORE Healthy Live Probiotics 50 Billion’ and ‘BYOCORE Healthy Live Probiotics 10 Billion,’ and is leading the rapidly evolving probiotic market trend toward high-dose and high-functionality products through a variety of functional items targeting not only gut health but also diet, vaginal health, and oral health.

To celebrate the 10th anniversary of BYOCORE’s launch, CJ Wellcare is also running a consumer promotion. Until January 31 next year, customers who purchase over 50,000 KRW at the Naver Brand Store will be entered into a draw where 100 winners will receive CJ gift certificates worth 100,000 KRW, along with various other events and special offers.

Lee Gyu-jin, Marketing Team Leader at CJ Wellcare, said, “To celebrate the 10th anniversary of the launch of ‘High-dose, High-functionality Probiotics BYOCORE,’ we have prepared a consumer promotion to thank our customers for their support.” He added, “We will continue to lead the microbiome field by launching various high-functionality products through ongoing probiotic research and development at our R&D center.”

This content was produced with the assistance of AI translation services.